NEWS AND EVENTS

The revenue model is based on razors (the hand-held reusable controller) and razor blades (the disposable fiber optic). We are not manufacturing needles (we will seek large needle manufacturers as potential partners). The BrightPointTM Epidural device is used with existing FDA cleared needles & syringes. The hand-held controller is a low cost, multi-use, medical device and has a two-year warranty. The fiber optic is a sterile, single-use disposable . The device will be cover

Clinician Training Tool The go-to-market strategy is to focus initially on teaching hospitals. Teaching hospitals comprise roughly 20% of...

Before developing the current product, Lumoptik conducted 3 physician focus groups with 21 anesthesiologists and nurse anesthetists. The...

Based on the feedback from clinicians in the market research focus groups the Lumoptik BrightPoint™ system has been designed with the...

Management plans to develop the next generation product after launching the epidural needle guidance product. A pipeline of products is...

The standard of care to perform epidural injections uses the technique called Loss of Resistance (LOR) which was first described in 1921....

A brief overview of the market opportunity: Large Market There are over 11 million epidural procedures performed in the US each year. It...

Cole Hatfield is a 20 year veteran of the electronic contract manufacturing industry, holding diverse leadership roles such as Director of Operations, and Plant and Production Manager. Mr. Hatfield has extensive experience with all aspects of manufacturing including mechanical assembly, manufacturing operations, logistics, supply chain management, launching new production operations and product lines, including the establishment of manufacturing facilities and processes. Cole